Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
|Articles|October 5, 2021
Pharmacy Clinical Pearl of the Day: Cold Symptoms vs Flu Symptoms
Author(s)Saro Arakelians, PharmD
With the arrival of flu and cold season, note the differences between symptoms for both illnesses.
Advertisement
Clinical Pearl of the Day: Cold vs Flu
Insight:
Cold symptoms
- Fever is rare
- Aches and pain are slight
- Symptoms are gradual
- Sneezing is common
- Stuffy nose is common
- Headaches are rare
- Fatigue and weakness sometimes
- Sore throat common
Flu symptoms
- Fever and chills are common
- Aches and pains are usual
- Symptoms are abrupt
- Sneezing occurs sometimes
- Stuffy nose occurs sometimes
- Headaches are common
- Fatigue and weakness are typical
- Sore throat occurs sometimes
Sources:
Advertisement
Related to this article
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
2
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
5